BlueCrest Capital Management’s Roan Resources, Inc. ROAN Stock Holding History

BlueCrest Capital Management’s Portfolio ROAN Stock Details ROAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-43,000	Closed	-$263K	–	1233
2019 Q1	$263K	Buy	+43,000	New	+$373K	0.01%	783

Other funds holding ROAN

JVL Advisors Houston, Texas $14.6M AUM 82.81% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Lasry Marc $15.1M AUM 10.39% 1-Year Est. Return

Raffles Associates New York $115M AUM 35.69% 1-Year Est. Return

Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return

Canyon Capital Advisors Dallas, Texas $772M AUM 32.81% 1-Year Est. Return

BlueCrest Capital Management's ROAN Position: Q2 2019 in Review

BlueCrest Capital Management sold out of Roan Resources, Inc. (ROAN) in Q2 2019, closing a stake of 43,000 shares — an estimated $263K sold.

BlueCrest Capital Management first reported a position in ROAN in Q1 2019 and held it in 1 quarter. The position peaked at $263K in Q1 2019. 92 funds tracked by Wall St. Rank hold ROAN as of Q2 2019.

BlueCrest Capital Management reported no remaining Roan Resources, Inc. position as of Q2 2019 after selling out during the quarter.
BlueCrest Capital Management sold 43,000 Roan Resources, Inc. shares in Q2 2019, an estimated $263K.
BlueCrest Capital Management first reported a position in Roan Resources, Inc. in Q1 2019 and held it in 1 quarter.
BlueCrest Capital Management's Roan Resources, Inc. position peaked at $263K in Q1 2019.
92 funds tracked by Wall St. Rank held Roan Resources, Inc. as of Q2 2019.

Based on BlueCrest Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.